All Stories

  1. SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience

    Article • PLoS ONE, May 2019, PLOS

    Dr Mangia Alessandra

  2. A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B

    Article • Alimentary Pharmacology & Therapeutics, July 2018, Wiley

    Professor Thomas Berg, Dr Mangia Alessandra

  3. Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review

    Article • Journal of Viral Hepatitis, April 2018, Wiley

    Dr Mangia Alessandra

  4. Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir-containing regimens

    Article • Journal of Viral Hepatitis, December 2017, Wiley

    Dr Mangia Alessandra

  5. Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis

    Article • Liver International, October 2017, Wiley

    Dr Mangia Alessandra

  6. Editorial: good news to patients with thalassaemia-HCV clearance made easy with direct acting antivirals. Authors’ reply

    Article • Alimentary Pharmacology & Therapeutics, August 2017, Wiley

    Dr Mangia Alessandra

  7. Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion-dependent thalassaemia and HCV genotype 1 or 4 infection

    Article • Alimentary Pharmacology & Therapeutics, June 2017, Wiley

    Dr Mangia Alessandra

  8. The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B

    Article • Hepatology, April 2017, Wiley

    Professor Thomas Berg, Prof Henry LY Chan, Dr Mangia Alessandra

  9. The combination of daclatasvir and sofosbuvir for curing genotype 2 patients who cannot tolerate ribavirin

    Article • Liver International, February 2016, Wiley

    Dr Mangia Alessandra

  10. Interleukin-28B genetic variants in untreated Italian HCV-infected patients: a multicentre study

    Article • Liver International, July 2014, Wiley

    Dr Mangia Alessandra

  11. In routine clinical practice, few physicians use early viral kinetics to guide HCV dual therapy treatment decisions

    Article • Liver International, November 2013, Wiley

    Dr Mangia Alessandra